Male patients with papillary thyroid cancer have a higher risk of extranodal extension
Author:
Funder
Henan Health Commission
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Link
https://link.springer.com/content/pdf/10.1007/s10147-021-02109-1.pdf
Reference23 articles.
1. Jeon MJ, Chun SM, Lee JY et al (2019) Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis. Endocrine 64(1):130–138. https://doi.org/10.1007/s12020-019-01842-y
2. Kim HI, Hyeon J, Park SY et al (2019) Impact of extranodal extension on risk stratification in papillary thyroid carcinoma. Thyroid 29(7):963–970. https://doi.org/10.1089/thy.2018.0541
3. Kim K, Zheng X, Kim JK et al (2020) The contributing factors for lateral neck lymph node metastasis in papillary thyroid microcarcinoma (PTMC). Endocrine 69(1):149–156. https://doi.org/10.1007/s12020-020-02251-2
4. Roh JL, Park JW, Jeong J et al (2017) Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma. J Surg Oncol 116(4):450–458. https://doi.org/10.1002/jso.24713
5. Lang BH, Shek TW, Wan KY (2016) Impact of microscopic extra-nodal extension (ENE) on locoregional recurrence following curative surgery for papillary thyroid carcinoma. J Surg Oncol 113(5):526–531. https://doi.org/10.1002/jso.24180
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unexpected 99mTc-pertechnetate avidity of lymph node metastases redicts better response to radioiodine therapy in differentiated hyroid cancer patients with lymph node metastases;American Journal of Nuclear Medicine and Molecular Imaging;2024
2. Relationship of Recurrence Rate with some Characteristics in Patients with Thyroid Carcinoma;Indian Journal of Endocrinology and Metabolism;2023-11
3. Predictors of Recurrence in Patients with Papillary Thyroid Carcinoma: Does Male Sex Matter?;Cancers;2022-04-09
4. 2-[18F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study;Diagnostics;2022-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3